AVDL logo

Avadel Pharmaceuticals plc (AVDL) Accounts receivable

Annual accounts receivable:

$34.10M+$21.99M(+181.72%)
December 31, 2024

Summary

  • As of today (September 17, 2025), AVDL annual accounts receivable is $34.10 million, with the most recent change of +$21.99 million (+181.72%) on December 31, 2024.
  • AVDL annual accounts receivable is now at all-time high.

Performance

AVDL Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLbalance sheet metrics

Quarterly accounts receivable:

$40.63M-$950.00K(-2.28%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL quarterly accounts receivable is $40.63 million, with the most recent change of -$950.00 thousand (-2.28%) on June 1, 2025.
  • Over the past year, AVDL quarterly accounts receivable has increased by +$7.25 million (+21.73%).
  • AVDL quarterly accounts receivable is now -2.28% below its all-time high of $41.58 million, reached on March 31, 2025.

Performance

AVDL Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

AVDL Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+181.7%+21.7%
3 y3 years--
5 y5 years+311.8%+613.8%

AVDL Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+181.7%-2.3%+2189.1%
5 y5-yearat high>+9999.0%-2.3%>+9999.0%
alltimeall timeat high>+9999.0%-2.3%>+9999.0%

AVDL Accounts receivable History

DateAnnualQuarterly
Jun 2025
-
$40.63M(-2.3%)
Mar 2025
-
$41.58M(+21.9%)
Dec 2024
$34.10M(+181.7%)
$34.10M(-8.1%)
Sep 2024
-
$37.10M(+11.2%)
Jun 2024
-
$33.38M(+47.1%)
Mar 2024
-
$22.69M(+87.5%)
Dec 2023
$12.10M(>+9900.0%)
$12.10M(+94.0%)
Sep 2023
-
$6.24M(+251.5%)
Jun 2023
-
$1.77M(>+9900.0%)
Dec 2020
$0.00(-100.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(-100.0%)
Jun 2020
-
$5.69M(-35.3%)
Mar 2020
-
$8.80M(+6.2%)
Dec 2019
$8.28M(-26.9%)
$8.28M(-5.1%)
Sep 2019
-
$8.72M(-14.2%)
Jun 2019
-
$10.17M(-13.6%)
Mar 2019
-
$11.77M(+3.9%)
Dec 2018
$11.33M(-23.4%)
$11.33M(+16.5%)
Sep 2018
-
$9.72M(-34.9%)
Jun 2018
-
$14.94M(-10.4%)
Mar 2018
-
$16.68M(+12.8%)
Dec 2017
$14.79M(-17.1%)
$14.79M(-38.6%)
Sep 2017
-
$24.08M(+24.9%)
Jun 2017
-
$19.29M(+43.2%)
Mar 2017
-
$13.46M(-24.5%)
Dec 2016
$17.84M(+138.3%)
$17.84M(+15.9%)
Sep 2016
-
$15.39M(+62.3%)
Jun 2016
-
$9.49M(+95.0%)
Mar 2016
-
$4.87M(-30.3%)
Dec 2015
$7.49M(+345.9%)
$6.98M(+315.6%)
Dec 2014
$1.68M(-72.9%)
$1.68M(-43.8%)
Sep 2014
-
$2.99M(-17.8%)
Jun 2014
-
$3.64M(-10.0%)
Mar 2014
-
$4.04M(-34.9%)
Dec 2013
$6.20M(+13.5%)
$6.20M(-1.9%)
Sep 2013
-
$6.33M(+25.6%)
Jun 2013
-
$5.04M(-4.0%)
Mar 2013
-
$5.25M(-3.9%)
Dec 2012
$5.46M(-29.6%)
$5.46M(-1.9%)
Jun 2012
-
$5.57M(-0.2%)
Mar 2012
-
$5.58M(-28.1%)
DateAnnualQuarterly
Dec 2011
$7.76M(+3.8%)
$7.76M(+25.2%)
Sep 2011
-
$6.20M(+7.1%)
Jun 2011
-
$5.79M(-21.8%)
Mar 2011
-
$7.40M(-1.1%)
Dec 2010
$7.48M(-13.8%)
$7.48M(-26.9%)
Sep 2010
-
$10.23M(+65.3%)
Jun 2010
-
$6.19M(-14.3%)
Mar 2010
-
$7.22M(-16.8%)
Dec 2009
$8.68M(+24.3%)
$8.68M(+18.2%)
Sep 2009
-
$7.34M(-15.5%)
Jun 2009
-
$8.69M(-14.2%)
Mar 2009
-
$10.13M(+45.1%)
Dec 2008
$6.98M(+39.9%)
$6.98M(-2.1%)
Sep 2008
-
$7.13M(+16.2%)
Jun 2008
-
$6.14M(-4.3%)
Mar 2008
-
$6.41M(+28.5%)
Dec 2007
$4.99M(-10.7%)
$4.99M(-35.8%)
Sep 2007
-
$7.76M(+12.2%)
Jun 2007
-
$6.92M(+17.8%)
Mar 2007
-
$5.88M(+5.2%)
Dec 2006
$5.58M(+116.1%)
$5.58M(-22.2%)
Sep 2006
-
$7.18M(+21.1%)
Jun 2006
-
$5.93M(+84.8%)
Mar 2006
-
$3.21M(+24.2%)
Dec 2005
$2.58M(-68.5%)
$2.58M(-58.6%)
Sep 2005
-
$6.24M(-14.0%)
Jun 2005
-
$7.25M(-14.2%)
Mar 2005
-
$8.46M(+3.1%)
Dec 2004
$8.20M(-2.0%)
$8.20M(+57.4%)
Sep 2004
-
$5.21M(0.0%)
Jun 2004
-
$5.21M(-32.8%)
Mar 2004
-
$7.75M(-7.3%)
Dec 2003
$8.37M(+141.7%)
$8.37M(+92.5%)
Sep 2003
-
$4.35M(-27.6%)
Jun 2003
-
$6.01M(+71.5%)
Mar 2003
-
$3.50M(+1.2%)
Dec 2002
$3.46M(-54.4%)
$3.46M(+17.8%)
Sep 2002
-
$2.94M(-61.3%)
Dec 2001
$7.60M(+187.6%)
$7.60M(+187.6%)
Dec 2000
$2.64M(+63.9%)
$2.64M
Dec 1999
$1.61M
-

FAQ

  • What is Avadel Pharmaceuticals plc annual accounts receivable?
  • What is the all time high annual accounts receivable for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual accounts receivable year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly accounts receivable year-on-year change?

What is Avadel Pharmaceuticals plc annual accounts receivable?

The current annual accounts receivable of AVDL is $34.10M

What is the all time high annual accounts receivable for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual accounts receivable is $34.10M

What is Avadel Pharmaceuticals plc annual accounts receivable year-on-year change?

Over the past year, AVDL annual accounts receivable has changed by +$21.99M (+181.72%)

What is Avadel Pharmaceuticals plc quarterly accounts receivable?

The current quarterly accounts receivable of AVDL is $40.63M

What is the all time high quarterly accounts receivable for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly accounts receivable is $41.58M

What is Avadel Pharmaceuticals plc quarterly accounts receivable year-on-year change?

Over the past year, AVDL quarterly accounts receivable has changed by +$7.25M (+21.73%)
On this page